Ameritas Investment Partners’s Caribou Biosciences CRBU Stock Holding History

Ameritas Investment Partners’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.7K	Buy	+8,334	New	+$16.5K	﹤0.01%	2903
2025 Q2	–	Sell	-7,487	Closed	-$6.84K	–	3231
2025 Q1	$6.84K	Hold	7,487	–	–	﹤0.01%	2910
2024 Q4	$11.9K	Hold	7,487	–	–	﹤0.01%	2855
2024 Q3	$14.7K	Hold	7,487	–	–	﹤0.01%	2785
2024 Q2	$12.3K	Hold	7,487	–	–	﹤0.01%	2847
2024 Q1	$38.5K	Hold	7,487	–	–	﹤0.01%	2283
2023 Q4	$42.9K	Hold	7,487	–	–	﹤0.01%	2256
2023 Q3	$35.8K	Buy	7,487 +3,542	+90%	+$22K	﹤0.01%	2275
2023 Q2	$16.8K	Hold	3,945	–	–	﹤0.01%	2650
2023 Q1	$20.9K	Hold	3,945	–	–	﹤0.01%	2447
2022 Q4	$25.4K	Hold	3,945	–	–	﹤0.01%	2456
2022 Q3	$41K	Hold	3,945	–	–	﹤0.01%	2127
2022 Q2	$21K	Hold	3,945	–	–	﹤0.01%	2522
2022 Q1	$36K	Buy	3,945 +2,475	+168%	+$26.1K	﹤0.01%	2248
2021 Q4	$22K	Hold	1,470	–	–	﹤0.01%	2594
2021 Q3	$35K	Buy	+1,470	New	+$35.9K	﹤0.01%	2376

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameritas Investment Partners's CRBU Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 8,334 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #2903 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in CRBU as recently as Q1 2025.

Ameritas Investment Partners first reported a position in CRBU in Q3 2021 and has held it in 16 quarters since. The position peaked at $42.9K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Ameritas Investment Partners held 8,334 shares of Caribou Biosciences worth $14.7K as of Q2 2026.
Caribou Biosciences was a new Ameritas Investment Partners position in Q2 2026.
Caribou Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2903 holding.
Ameritas Investment Partners first reported a position in Caribou Biosciences in Q3 2021 and has held it in 16 quarters since.
Ameritas Investment Partners's Caribou Biosciences position peaked at $42.9K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.